Correction: A Guideline and Checklist for Initiating and Managing Clozapine Treatment in Patients with Treatment-Resistant Schizophrenia.

Correll, C U; Agid, Ofer; Crespo-Facorro, Benedicto; de Bartolomeis, Andrea; Fagiolini, Andrea; Seppälä, Niko; Howes, Oliver D

Correll, C U; Agid, Ofer; Crespo-Facorro, Benedicto; de Bartolomeis, Andrea; Fagiolini, Andrea; Seppälä, Niko; Howes, Oliver D.

Afiliação

Correll CU; Department of Child and Adolescent Psychiatry, Charité Universitätsmedizin Berlin, Berlin, Germany.
Agid O; Department of Psychiatry and Molecular Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, NY, USA.
Crespo-Facorro B; Department of Psychiatry, The Zucker Hillside Hospital, Northwell Health, Glen Oaks, NY, USA.
de Bartolomeis A; Department of Psychiatry, University of Toronto, Toronto, Canada.
Fagiolini A; CIBERSAM, Hospital Universitario Virgen del Rocío, IBiS, Universidad de Sevilla, Sevilla, Spain.
Seppälä N; Section on Clinical Psychiatry and Psychology, Laboratory of Molecular and Translational Psychiatry and Unit of Treatment Resistant Psychosis, University of Naples Federico II, Naples, Italy.
Howes OD; Department of Molecular Medicine, University of Siena, Siena, Italy.

CNS Drugs ; 36(9): 1015, 2022 Sep.

Article em En | MEDLINE | ID: mdl-35976566

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: CNS Drugs Assunto da revista: FARMACOLOGIA / NEUROLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google